💡 Video Interpretation by Amgad N. Makaryus — Beyond Glucose Control: GLP-1 Agonists & Blood Pressure Are we overlooking the cardiovascular potential of GLP-1 receptor agonists beyond glycemic control? 👉 Watch the video: imrpress.com/journal/RCM/vid… 🎥 In this video, Amgad N. Makaryus explores how GLP-1 RAs influence blood pressure via vascular, renal, and metabolic pathways—backed by major clinical trials. From modest BP reductions to broader cardiometabolic benefits, their role as an adjunctive strategy is gaining increasing attention. ✒️ Authors: Dhir Gala, Fady Botros, Amgad N. Makaryus @AmgadMakaryus 🏪 Affiliation: Rutgers New Jersey Medical School @Rutgers_NJMS ; Northwell Health; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell @ZuckerSoM 📄 Read the article: imrpress.com/journal/RCM/26/… #Cardiology #Hypertension #Diabetes #CardiometabolicHealth #ClinicalResearch #Medicine

💡 Can cancer survivors with end-stage HF thrive after #HeartTransplant in the #VAD era? #CardioOncology #HeartFailure 🧠 The latest work from Methodist Children's Hospital @SAHealth210 by first author Dr. Bibhuti B. Das and his team is now featured in RCM! 👉: imrpress.com/journal/RCM/27/… #Cardiology #Cardiomyopathy #CardioOncology #HeartTransplant #HeartFailure #VAD #CancerSurvivors #Chemotherapy #PediatricCardiology #Oncology

💡 What's blocking #ACS guidelines from saving more lives at the bedside? #STEMI #Cardiology #PCI 🧠The latest work from the University of Southern Queensland @unisqaus by first author Dr. Snezana Stolic and her team is now featured in RCM! 👉: imrpress.com/journal/RCM/27/… #CardioTwitter #HeartHealth #EmergencyMedicine #AcuteCoronarySyndrome #Cardiology #STEMI #NSTEMI #CardiovascularDisease #HeartHealth #PCI #ClinicalGuidelines #HealthcareQuality #ImplementationScience #SystematicReview #Nursing #GlobalHealth

📢 Spotlight on RCM Editorial Board Member: Prof. Juan J Badimon, PhD, FACC, FAHA (@IcahnMountSinai). ✨A leading figure in cardiology, his profound expertise in CVD prevention and atherothrombosis ensures the highest scientific standards. 🫀🔬 👉 Explore his work:profiles.icahn.mssm.edu/juan… #Cardiology #HeartFailure #CVDPrevention

📚 1,900 publications. H-index of 165. And still never misses a day of running. 🏃 💨 How does cardiology powerhouse Prof. Carl "Chip" Lavie stay at the top of both the clinic 🏥 and the research? 🔬 We sat down with the Reviews in Cardiovascular Medicine (RCM) Editorial Board Member 🎙️ to unpack: ✅ 🏅 The "golden rules" of exercise dose — maximizing gains, minimizing risk ✅ ⚡ His secret to handling 35 manuscripts every week ✅ 🧠 Sharp takes on the obesity paradox & Omega-3 in CVD 🐟 Heart health isn't just medicine — it's a way of life. ❤️ 🔗 Read the full interview 👉: imrpress.com/journal/RCM/pag… #HeartHealth #Cardiology #MedEd #FitnessScience #ResearchLife #PreventiveHealth #RCM #MarathonRunner #MedTwitter

💡Can #OxidativeStress in #Cardiomyocytes be detected through #BreathAnalysis to revolutionize #IschemicHeartDisease diagnostics? This study maps the journey of #VOCs from heart to breath, revealing a #Breathomics signature for #IHD. 🧠The latest work from Sechenov University by first author Dr. Basheer Abdullah Marzoog @basheermarzoog and his team is now featured in RCM! 👉: imrpress.com/journal/RCM/27/… #Cardiology #VOCs #HeartHealth #MedTwitter #Biomarkers #CardioEd

💡Can #VulnerablePlaque imaging prevent #CAD events before they happen? 🫀 🧠The latest work from South Padova General Hospitals by Dr. @Venezianofa and his team is now featured in RCM! 👉: imrpress.com/journal/RCM/27/… #Cardiology #Imaging #MedTwitter #CardioTwitter #VulnerablePlaque #CardiovascularImaging #Atherosclerosis #CCTA #OCT #MedEd #HeartHealth #ClinicalResearch #MedTwitter

💡"In 1,000 matched #TAVI pairs, does #Anesthesia choice change who gets pneumonia—or survival? #Cardiology" 🧠The latest work from @HdzNrw by first author Dr. Astrid Bergmann and her team is now featured in RCM! 👉: imrpress.com/journal/RCM/27/… #TAVR #CardiacAnesthesia #AorticStenosis #Cardiology #HeartValve #StructuralHeart #InterventionalCardiology #PatientSafety

🫀 New Interview Alert | Reviews in Cardiovascular Medicine 🌟 What does the future of sports cardiology look like? 🏃‍♂️💓 How can we better understand athlete’s bradycardia, improve ECG screening, and prevent sudden cardiac death in athletes? 🚨 In our latest special interview, Reviews in Cardiovascular Medicine speaks with Associate Prof. Alessandro Zorzi, MD, PhD, FESC, Editorial Board Member of RCM and Associate Professor of Cardiology at the University of Padova, Italy 🇮🇹. Prof. Zorzi shares valuable insights into: 🏃‍♂️ Athlete’s bradycardia Distinguishing physiological adaptations from potential intrinsic nodal dysfunction. ⚡ Intrinsic vs. extrinsic cardiac mechanisms Understanding why long-term electrophysiological remodeling may matter for athlete health. 🤖 AI-assisted cardiovascular screening Exploring how AI may help differentiate benign training-related ECG changes from pathological patterns. 🚨 Sudden cardiac death prevention Emphasizing early recognition, risk stratification, and expert ECG interpretation. 📚 Open-access publishing and peer review Reflecting on rigorous academic standards, practical clinical guidance, and the future development of RCM. At Reviews in Cardiovascular Medicine, we are proud to support global academic exchange and clinically meaningful cardiovascular research 🌍🔬📝. 📖 Read the full interview here:​ imrpress.com/journal/RCM/pag… #Cardiology #SportsCardiology #CardiovascularMedicine #AthleteHealth #SuddenCardiacDeath #Arrhythmia #ECG #AIinHealthcare #DigitalHealth #PreventiveCardiology #OpenAccess #MedicalResearch #ClinicalResearch #AcademicPublishing #PeerReview #MedicalEducation #CardioTwitter #MedTwitter

🚨 It's #WorldHypertensionDay 🩺❤️ Hypertension affects 1.28B adults globally — and the science is evolving fast. 📚 Explore our NEW Special Collection from: 🔹 Reviews in Cardiovascular Medicine 🔹 The Heart Surgery Forum Top research on pulmonary HTN, vascular remodeling, exercise & surgical care ⬇️ 👉imrpress.com/page/WHD-specia… #Hypertension #Cardiology #HeartHealth #CardioTwitter #MedTwitter #BloodPressure #CVD #MedicalResearch

🌍🩺 It's #WorldHypertensionDay — "Controlling Hypertension Together!" RCM sits down with Prof. Stefano Omboni (Italian Institute of Telemedicine 🇮🇹) @StefanoOmboni on the future of BP care: 📡 Telemedicine for remote communities ⌚ Wearables & cuffless devices 🤖 AI — promise & pitfalls 🌐 Closing the global care gap 🔗 Read the full interview ⬇️ imrpress.com/journal/RCM/pag… #Hypertension #DigitalHealth #Cardiology #AI #Telemedicine #IMRPress #WorldHypertensionDay #DigitalHealth #AIinHealthcare #BloodPressure #CardiovascularMedicine #RCM #HealthEquity #MedicalResearch #Grok

🌍❤️ World Hypertension Day Special Interview !​ 🩺 RCM sits down with Prof. Ruan Kruger @ProfRuanKruger (@NWU_HART) — a global leader in pediatric hypertension — to unpack why BP control must start in childhood, not adulthood. 🧒📉 🔑 Key takeaways: ⌚ Wearables AI = the future of early screening 🌍 Africa needs more pediatric BP data — now 🏫 School-based screening saves lives 🤝 Bridging research → public action is critical 📖 Read the full interview 👇 imrpress.com/journal/RCM/pag… #WorldHypertensionDay #Hypertension #HeartHealth #PediatricHealth #AIinMedicine #GlobalHealth #IMRPress #RCM #CardiovascularHealth #PediatricHypertension #WorldHypertensionDay2026 #PreventiveCardiology #GlobalHealth #DigitalHealth #AIinHealthcare #PublicHealth

💡"Can routine #liver enzymes, platelets & #CA125 quietly predict who survives acute #HeartFailure?" 🧠The latest work from @dscneu by first author Dr. @SefaTatar and his team is now featured in Rev Cardiovasc Med! 👉: imrpress.com/journal/RCM/27/… #FIB4 #Cardiology #Biomarkers

🧠 Growing evidence shows that cardiovascular and neurodegenerative diseases share risk factors, mechanisms, and trajectories — making the heart–brain axis a critical frontier of modern medicine.​ 🌟We are honored to share a Special Interview with Dr. Allison B. Reiss @Dr__Reiss, Associate Professor of Medicine and Head of the Inflammation Laboratory at NYU Grossman Long Island School of Medicine @nyulangone , and Editorial Board Member of Reviews in Cardiovascular Medicine (RCM). As both a board-certified internal medicine physician and a molecular biologist, Dr. Reiss has spent her career working at the intersection of cardiometabolic disease and neurodegeneration — a space where bench-to-bedside thinking matters more than ever. In this conversation, she explores: 🔬 The heart–brain axis as a critical determinant of both lifespan and healthspan, and why subspecialization can blind us to the interdependence of these two organs. 🧬 The role of ApoE genetics, lipid biology, systemic and neuroinflammation as shared drivers of cardiovascular and neurodegenerative disease. 🤖 How AI, single-cell and spatial multi-omics, 3D imaging, organoid models, CRISPR-based editing, and engineered exosome/nanoparticle delivery are reshaping brain–heart systems biology and enabling dual-disease trials. 🌱 Why lifestyle — nutrient-dense diets, regular activity, quality sleep, social engagement, and stress management — remains one of the most powerful interventions we have for both organs. 👩‍⚕️ Her journey as a woman in medicine and science, the barriers she faced, and her advice to the next generation: do what you love, keep your dreams alive, find great mentors — and mentor others in return. 📚 Her vision for academic publishing: journals as trusted, unbiased platforms that disseminate validated science to clinicians, researchers, and the public alike. Dr. Reiss also shares thoughtful suggestions for RCM’s future — from Special Issue–themed webinars and awards for outstanding reviewers and authors, to a stronger, video-driven social media presence. A heartfelt thank you to Dr. Reiss for her time, candor, and vision. 👉 Read the full interview on the RCM website. imrpress.com/journal/RCM/pag… #CardiovascularMedicine #HeartBrainAxis #Neurodegeneration #AlzheimersResearch #Inflammation #TranslationalResearch #PrecisionMedicine #SingleCellOmics #SpatialTranscriptomics #AIinHealthcare #WomenInSTEM #WomenInMedicine #PhysicianScientist #OpenAccess #ScientificPublishing #IMRPress #ReviewsInCardiovascularMedicine #AI

💡 "What drives death from #InfectiveEndocarditis when #Cardiology meets #ConflictMedicine in a resource-limited tertiary center?" 🧠The latest work from @SanaaUniversity by first author Mohammed Abdul-Malik Ghalib and his team is now featured in Rev. Cardiovasc. Med.! 👉: imrpress.com/journal/RCM/27/… #GlobalHealth #SepticShock #AKI #Yemen #HeartHealth

🧐We warmly invite you to submit to the Special Issue: Optical Coherence Tomography in Percutaneous Coronary Intervention—Volume 2 From the University Hospital of Patras by Ass. Prof. @ankaranasos 📖 For more details, please see: imrpress.com/journal/RCM/spe… 👉 Intracoronary optical coherence tomography (OCT) is a high-resolution, infrared light-based imaging modality that can provide important information regarding the morphological characteristics of atherosclerotic plaques, as well as the effect of percutaneous coronary intervention (PCI). Specifically, OCT allows qualitative and quantitative assessment of microstructures such as the fibrous cap, lipid core, macrophages, calcium, cholesterol crystals, thrombus, and more. It has also been used in PCI for procedural guidance, guiding device selection for lesion preparation, providing quantitative measurements for sizing, and assessing stent expansion and PCI-induced vascular trauma. Moreover, OCT can provide useful information regarding the patho-mechanisms involved in stent failure. Recent evidence shows that OCT guidance in PCI may be associated with improved outcomes. This Special Issue focuses on: ✨ the role of OCT in procedural guidance ✨the use of OCT in the assessment of stent failure ✨OCT guidance in specific lesion subsets (bifurcations, calcified lesions, etc.) ✨insights into the mechanisms of atherosclerosis obtained by OCT ✨recent developments in intracoronary OCT imaging 🧠 Why submit to this Special Issue of RCM? ✔️ Open Access ✔️ Rapid review process ✔️ Impact Factor: 1.3 ✔️ Indexed in major databases 📕 Manuscript Type: Review、Systematic Review、Original Research、Opinion、Editorial et al. 📆 Submission deadline: 31 Dec 2026 ✍️ Submit your work to imr.propub.com 📑 Click here for author guidelines: imrpress.com/journal/RCM/pag… #OpticalCoherenceTomography #PercutaneousCoronaryIntervention #IntravascularImaging #InterventionalCardiology #CoronaryArteryDisease #Atherosclerosis #CardiovascularResearch #CoronaryStents #CallForPapers #IMRPress #RCMCFP

🧐NEW INTERVIEW 🚨 🔬We sat down with Prof. @atmbiopro (@VCU), RCM Editorial Board Member & a leading voice in cardiovascular & cardio-oncology research. She unpacks: 🧬 The pleiotropic miRNA-17-92 cluster 💊 PDE5 inhibitors vs. doxorubicin cardiotoxicity 🧪 mTOR signaling in the diabetic heart 🎯 Her new Special Issue on cardiac injury 💙 A heartfelt thank-you to Prof. Anindita Das for her dedication to mentorship, scientific rigor, and the global cardiovascular community. Read 👉imrpress.com/journal/RCM/pag… #Cardiology #CardioOncology #microRNA #HeartResearch #STEM #WomenInScience #IMRPress #CardiovascularResearch #TranslationalMedicine #HeartHealth #ScienceCommunication #WomenInSTEM #MedicalResearch #Cardiology

💡"What if a simple gas could make one of #EPeeps' riskiest steps in #VTablation far safer? #CO2 #Cardiology" 🧠The latest work from @ClevelandClinic by first author Dr. Koji Higuchi and his team is now featured in RCM! 👉: imrpress.com/journal/RCM/27/… #VentricularTachycardia #EPeeps #VTablation #CO2 #Cardiology #HeartRhythm #CardiacElectrophysiology #CatheterAblation #CardioTwitter #InterventionalCardiology #MedicalResearch #ClevelandClinic

The latest work from Sorbonne Université by first author Prof. Pierre F. SABOURET and his team is now featured in RCM! 👉 Explore the full study: imrpress.com/journal/RCM/27/… Article Highlights 💡 Does the clinical benefit of PCSK9 inhibitors truly depend on the drug type, or is it primarily driven by baseline LDL-C and patient risk profile? 💡 Why do trials like ODYSSEY OUTCOMES and FOURIER appear to show different patterns of benefit across LDL-C strata, and what explains these differences in real-world interpretation? 💡 Should alirocumab and evolocumab be considered clinically distinct, or are observed differences mainly a reflection of baseline risk, trial design, and treatment strategy rather than drug-specific biology? ✒️ Authors: Pierre Sabouret @SABOURETCardio (Corresponding author), Domenico Mario Giamundo @jamundus20 , Mamas Mamas @mmamas1973 🏪 Affiliation: Sorbonne University, “Tor Vergata” University @unitorvergata, University Hospitals of North Midlands NHS Trust, Keele University @KeeleUniversity 📖 Don’t miss this citable reference for your future research! Citation format: Pierre Sabouret, Domenico Mario Giamundo, Mamas Mamas. Focus on Baseline LDL-C and Patient Risk, Not Drug Type: A Perspective on Alirocumab vs Evolocumab. Rev. Cardiovasc. Med. 2026, 27(4), 50430. Welcome to submit your work via our submission link👉: imr.propub.com/ RCM welcomes review papers, research articles and other types of research in both cardiovascular medicine and cardiovascular disease. 📖 Click here for author guidelines: imrpress.com/journal/RCM/pag… #PCSK9Inhibitors #LDLCholesterol #CardiovascularRisk #Dyslipidemia #AtheroscleroticCardiovascularDisease

The latest work from University Hospital Alvaro Cunqueiro and University of Vigo @uvigo by first authors Dr. Carla Iglesias-Otero @igle_carla , Dr. Julio Echarte Morales @jcecharte and their team is now featured in RCM! Welcome to read this article 👉: imrpress.com/journal/RCM/27/… Article Highlights: 💡 Can #transcatheter edge-to-edge repair move beyond traditional indications for severe #mitralregurgitation? This review explores how M-#TEER is expanding into increasingly complex clinical scenarios, including #advancedheartfailure, acute #MR after #myocardialinfarction, and combined structural interventions, highlighting evolving strategies shaping contemporary #valve therapy. ✒️ Authors: Carla Iglesias-Otero @igle_carla ; Julio Echarte Morales @jcecharte ; David González-Fernández; Andrés Íñiguez-Romo @AndresIniguezR , Rodrigo Estévez-Loureiro @RodrigoEstvez1 (Corresponding author) 🏪 Affiliations: University Hospital Alvaro Cunqueiro; Universidade de Vigo @uvigo 📖 Don’t miss this citable reference for your future research! Citation format: Iglesias-Otero C, Echarte-Morales J, González-Fernández D, et al. Evolution of Clinical Indications for Mitral Valve Transcatheter Edge-to-Edge Repair. Rev. Cardiovasc. Med. 2026, 27(3), 47139. Welcome to submit your work via our submission link👉: imr.propub.com #RCM welcomes review papers, research articles and other types of research in both #cardiovascular medicine and cardiovascular disease. 📖 Click here for author guidelines: imrpress.com/journal/RCM/pag… #Cardiology #StructuralHeartDisease #MitralValve #InterventionalCardiology #RCMPaper

📣 Graphical Abstract: Disruption of the Fibroinflammatory Loop: A Therapeutic Strategy for Cardiac Fibrosis in Non-Ischemic Cardiomyopathy 👉 Explore the full Graphical Abstract: imrpress.com/journal/RCM/pag… Are we missing a key factor in why cardiac fibrosis persists in non-ischemic cardiomyopathy despite treatment? This study reframes fibrosis as a self-reinforcing fibroinflammatory cycle driven by mechano-inflammatory feedback, highlighting emerging strategies to disrupt these chronic remodeling loops. ✒️ Authors: Hongyu Qiu, Inna P. Gladysheva 🏪 Affiliation: University of Arizona @uarizona 📖 Article: imrpress.com/journal/RCM/27/… #Cardiology #CardiacFibrosis #Cardiomyopathy #TranslationalMedicine #HeartFailure #Research #RCMPaper